Showing results (1301-1310 of 1,397) with videos related to

Sort By:
Pageof 140
American Journal of Medical Genetics. Part A|June 19, 2024
Known pathogenic gene variants and new candidates detected in sudden unexpected infant death using whole genome sequencingAngela M Bard, Lindsay V Clark, Erdal Cosgun, et al.
Molecular Cell|June 14, 2025
CRAMP1 drives linker histone expression to enable Polycomb repressionRachael E Matthews, Joshua Miguel C Danac, Emily L Naden, et al.
Journal of Fish Biology|March 30, 2024
Cost-benefit analysis of ecosystem modeling to support fisheries managementMatthew H Holden, Eva E Plagányi, Elizabeth A Fulton, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligandH Hsu, D L Lacey, C R Dunstan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2020
TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarkerE L Mayer, V Abramson, R Jankowitz, et al.
Molecular Human Reproduction|July 8, 2025
WERF Endometriosis Phenome and Biobanking Harmonisation Project for Experimental Models in Endometriosis Research (EPHect-EM-Homologous): homologous rodent modelsKatherine A Burns, Daniëlle Peterse, Caroline B Appleyard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancerBryan T J Hennessy, Kirsten M Timms, Mark S Carey, et al.
Human Genetics|April 18, 2003
Linkage and association mapping of the LRP5 locus on chromosome 11q13 in type 1 diabetesRebecca C J Twells, Charles A Mein, Felicity Payne, et al.
Iscience|December 1, 2021
Spiny mice activate unique transcriptional programs after severe kidney injury regenerating organ function without fibrosisDaryl M Okamura, Chris M Brewer, Paul Wakenight, et al.
Investigational New Drugs|January 10, 2018
A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancerDiane A J van der Biessen, Jourik A Gietema, Maja J A de Jonge, et al.
Pageof 140